Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04954157 · ClinicalTrials.gov registry record · NA
Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT04954157 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 80 participants.
The verdict
NCT04954157, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The two-part phases will each have a unique patient population, The goal in this application is to see if that carotid bodies are "offline" is correct and to determine whether a cohort of SARS-Cov-2 patients can be identified who fit this profile and would be suitable for drug treatment. The testing will require one group of subjects to hold their breaths for a short period while the investigators monitor vital signs and blood O2 levels. A second group of "healthier" COVID subjects will be asked perform a walk-test inside their rooms for six minutes while vital signs are monitored as well as blood O2 levels. If the subjects are in the healthy control group, they will perform the walk test in a designated hallway at the medical center also while there vitals are being monitored. The goal, using a mild stimulus, is to determine whether respiration increases if blood O2 saturation is decreased. If it does not, that would indicate a failure of the carotid body oxygen sensing system.
Interventions
- DIAGNOSTIC_TEST Phase-1: Breath Holding Test
- DIAGNOSTIC_TEST Phase 2: 6-Minute Walk Test (6MWT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2022-04-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04954157
The ClinicalTrials.gov registry entry for NCT04954157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phase-1: Breath Holding Test is the first listed.
NCT04954157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04954157 about?
NCT04954157 is a clinical study titled "Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients". The two-part phases will each have a unique patient population, The goal in this application is to see if that carotid bodies are "offline" is correct and to determine whether a cohort of SARS-Cov-2 patients can be identified who fit this profile and would be suitable for drug treatment. The testin...
What is the current status of trial NCT04954157?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2020-06-29. Estimated completion is 2022-04-21.
What interventions are being tested in trial NCT04954157?
The interventions under investigation include: Phase-1: Breath Holding Test (DIAGNOSTIC_TEST), Phase 2: 6-Minute Walk Test (6MWT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04954157?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.